HK40036660B - Anti-cd25 for tumour specific cell depletion - Google Patents

Anti-cd25 for tumour specific cell depletion

Info

Publication number: HK40036660B
Authority: HK; Hong Kong
Prior art keywords: specific cell; cell depletion; tumour specific; tumour; depletion
Prior art date: 2018-03-13

Application number

HK62021026521.6A

Other languages

Chinese (zh)

Other versions

HK40036660A (en

Inventor

安妮·古比耶

贝特里兹·古耶内切亚·科尔佐

约瑟芬·萨利姆

凯文·莫尔德

帕斯卡·梅希尔

塞尔吉奥·克萨达

Original Assignee

塔斯克疗法有限公司

癌症研究技术有限公司

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2018-03-13

Filing date

2019-03-13

Publication date

2025-09-05

2019-03-13 Application filed by 塔斯克疗法有限公司, 癌症研究技术有限公司 filed Critical 塔斯克疗法有限公司

2021-05-28 Publication of HK40036660A publication Critical patent/HK40036660A/en

2025-09-05 Publication of HK40036660B publication Critical patent/HK40036660B/en

Links

HK62021026521.6A 2018-03-13 2019-03-13 Anti-cd25 for tumour specific cell depletion HK40036660B (en)

Applications Claiming Priority (9)

Application Number	Priority Date	Filing Date	Title
US62/642,243		2018-03-13
US62/642,218		2018-03-13
US62/642,230		2018-03-13
US62/642,232		2018-03-13
US62/642,248		2018-03-13
EPPCT/EP2018/056312		2018-03-13
GB1804027.9		2018-03-13
GB1804029.5		2018-03-13
GB1804028.7		2018-03-13

Publications (2)

Publication Number	Publication Date
HK40036660A HK40036660A (en)	2021-05-28
HK40036660B true HK40036660B (en)	2025-09-05

Family

ID=

Similar Documents

Publication	Publication Date	Title
SG11202008733YA (en)	2020-10-29	Anti-cd25 for tumour specific cell depletion
IL269081A (en)	2019-11-28	Fc-optimized anti-cd25 for tumour specific cell depletion
EP3649153B8 (en)	2025-07-16	Fc optimised anti-cd25 antibodies for tumor specific cell depletion
IL278204A (en)	2020-11-30	Anti-bcma car-t-cells for plasma cell depletion
IL287440A (en)	2021-12-01	Antigen specific cd19-targeted car-t cells
GB201819540D0 (en)	2019-01-16	T cell modification
EP3805270A4 (en)	2022-03-09	Improved anti-cd19 car-t cell
EP3806894A4 (en)	2022-06-08	Plap-car-effector cells
EP3834485A4 (en)	2022-04-27	Euca secondary cell direct activation
EP3842513A4 (en)	2022-06-29	Cell incubator
EP3829777B8 (en)	2023-12-06	Flotation cell
EP3858974A4 (en)	2022-06-29	Cell culture chip
EP3484525A4 (en)	2020-07-29	Multivirus-specific t cell immunotherapy
IL276992A (en)	2020-10-29	Anti-cd25 for tumour specific cell depletion
CA185441S (en)	2020-01-16	Cell culture insert
HK40036661B (en)	2025-03-07	Anti-cd25 for tumour specific cell depletion
HK40036659B (en)	2025-08-22	Anti-cd25 for tumour specific cell depletion
HK40038007B (en)	2025-09-05	Anti-cd25 for tumour specific cell depletion
HK40038006B (en)	2025-04-03	Anti-cd25 for tumour specific cell depletion
HK40038005B (en)	2025-04-17	Anti-cd25 for tumour specific cell depletion
HK40036660B (en)	2025-09-05	Anti-cd25 for tumour specific cell depletion
HK40036205B (en)	2025-04-03	Anti-cd25 for tumour specific cell depletion
CA185442S (en)	2020-01-16	Cell culture insert
HK40016585B (en)	2025-05-16	Fc-optimized anti-cd25 for tumor specific cell depletion
PT3596123T (en)	2024-04-11	Fc-optimized anti-cd25 for tumour specific cell depletion